top of page
Search By Tags



Invalidated IP Rights & Cost Liabilities: Lessons from Crocs v. Bata
Introduction When a statutory intellectual property right gets wiped off the register mid-litigation, who bears the burden of the legal fees incurred along the way? Recently in the case of Crocs Inc. USA v. M/s Bata India Ltd. & Ors.[1], the Delhi High Court examined whether a defendant can recover actual litigation costs under Section 35 of the Code of Civil Procedure, 1908 (CPC), as amended by the Commercial Courts Act, 2015, after a design infringement suit becomes infruct

Vrinda Sehgal
Sep 1


Array Biopharma INC v. Deputy Controller of Patents and Designs: A case study
In a significant ruling on the patentability of pharmaceutical combination inventions, the Delhi High Court set aside an order from the Indian Patent Office refusing the grant of a patent for a triple-drug combination used in cancer treatment, under Indian Patent Application No. 450/DELNP/2015, titled "Pharmaceutical Combination Comprising a BRAF Inhibitor, an EGFR Inhibitor and Optionally a PI3K Alpha Inhibitor. Aggrieved by the rejection from the Indian Patent Office, th

Ranjna Mehta-Dutt
Aug 31


Beyond Procedural Technicalities: The Delhi High Court's Approach to Trademark Renewal under Section 25(3)
Introduction Trademark registrations rarely lapse due to deliberate abandonment. More often they are lost quietly, because a renewal notice went to the wrong desk and nobody was left to answer it. That is essentially what happened to the mark “B.P.R.”, used since 1979 and registered in 1999, and it eventually brought Rajinder Singh to the Delhi High Court, more than six years after his registration lapsed for want of a notice that never reached him. The judgment is barely a d

Niharika Puri
Aug 26


Novartis Ag. v Venkata Narayana Active Ingredients Pvt. Ltd.- Extent of exemption under the Bolar provision- A case study
Deliberating and dissecting the provision of Section 107- A, the Madras High Court has delved much deeper in explaining the Bolar exemptions in a post-trial judgement in the case of Novartis Ag. v Venkata Narayana Active Ingredients Pvt. Ltd. The Court decreed patent infringement holding that the defendant Venkata Narayana Active Ingredients Pvt. Ltd's manufacture and export of Vildagliptin API used for treating type-2 diabetes infringed Novartis's Indian Patent No. 212

Ranjna Mehta-Dutt
Aug 24


"Common General Knowledge" Is Not Enough: Bombay High Court Sets Aside Patent Refusal
In a significant judgment, the Hon'ble Bombay High Court has set aside an order refusing Deepak Nitrite Limited's patent application, reiterating that patent refusals under Section 15 of the Patents Act must be supported by cogent reasoning, proper inventive step analysis, and identifiable evidence, particularly where the Controller relies on "common general knowledge." Background The petition concerned Patent Application No. 202021019409 titled "A Free-Flowing Food Grade Sod

Nanki Arneja
Aug 13


From Prior User to Prior Registrant: Rethinking Trademark Exhaustion
Introduction In many instances, a cross-border distribution agreement can create an interesting trademark issue: A foreign manufacturer allows an Indian party to register and use the trademark in India and the Indian party develops goodwill based on such trademark registration and then the relationship goes sour between them. The question is then whether the rights of the first user of the mark overseas and who has continued to supply goods in India is superior to the rights

Medhavi Capoor
Aug 5


Intra-cellular therapies Vs. Controller of patents- A case study
On July 6, dismissing the appeal filed by Intra-cellular Therapies , the Delhi High Court upheld the Controller's decision on the grounds of lack of novelty and non-patentability under Section 3(d) while choosing not to delve into the more rigorously contested inventive-step objection. Besides dealing with the controversial coverage/ disclosure dichotomy, the discussion focused on the “person in the know” versus the "person ordinarily skilled in the art" and the missing lin

Ranjna Mehta-Dutt
Jul 27


Four Oppositions, Fifteen Years, One Grant: The Indian Patent Office's Ribociclib Decision
Novartis AG and Astex Therapeutics Ltd. have finally received a grant of a patent under number 594997 for their application relating to Ribociclib (Kisqali®), a selective CDK4/6 inhibitor indicated for the treatment of HR+/HER2- breast cancer, after contesting four pre-grant oppositions filed against the application in an exhaustive and detailed 198-page order. The application drew oppositions from Natco Pharma and three individual Opponents. The application was filed in 20

Ranjna Mehta-Dutt & Nanki Arneja
Jul 23


Too Close for Comfort: Bombay High Court Holds 'Super Asian Plus' Deceptively Similar To 'Asian Paints
Introduction Recently, in the case of Asian Paints Limited vs. Manju Rani Jindal1, the Bombay High Court discussed the issue of deceptive similarity between two marks. The Court granted a permanent injunction in favour of the Plaintiff, restraining the Defendant from manufacturing, marketing, selling and/or likely to market and sell and/or using in any manner whatsoever in relation to wall putty, cement paints and other goods used in the paint industry, the impugned mark “SUP

Soumya Juneja
Jul 20


The exclusivity paradox: Lessons from Honasa Consumer Ltd. v. Visage Beauty
INTRODUCTION The increasing use of function-oriented product descriptors in the cosmetics and personal care industry has intensified the tension between commercial branding practices and the distinctiveness requirement under trademark law. While descriptive expressions may effectively communicate a product's purpose or characteristics, they ordinarily remain incapable of distinguishing commercial origin and are therefore excluded from trademark protection, as granting a monop

Bhawna Mangla
Jul 18
Archive
bottom of page

























